These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38387507)

  • 1. Missense variants in phospholamban and cardiac myosin binding protein identified in patients with a family history and clinical diagnosis of dilated cardiomyopathy.
    Armanious GP; Lemieux MJ; Espinoza-Fonseca LM; Young HS
    Biochim Biophys Acta Mol Cell Res; 2024 Apr; 1871(4):119699. PubMed ID: 38387507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic mutations and mechanisms in dilated cardiomyopathy.
    McNally EM; Golbus JR; Puckelwartz MJ
    J Clin Invest; 2013 Jan; 123(1):19-26. PubMed ID: 23281406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain.
    Huang W; Liang J; Yuan CC; Kazmierczak K; Zhou Z; Morales A; McBride KL; Fitzgerald-Butt SM; Hershberger RE; Szczesna-Cordary D
    FEBS J; 2015 Jun; 282(12):2379-93. PubMed ID: 25825243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase and phospholamban protein expression.
    Kim HW; Ch YS; Lee HR; Park SY; Kim YH
    Life Sci; 2001 Dec; 70(4):367-79. PubMed ID: 11798007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
    Minamisawa S; Hoshijima M; Chu G; Ward CA; Frank K; Gu Y; Martone ME; Wang Y; Ross J; Kranias EG; Giles WR; Chien KR
    Cell; 1999 Oct; 99(3):313-22. PubMed ID: 10555147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode.
    Li Z; Chen P; Xu J; Yu B; Li X; Wang DW; Wang DW
    Int J Cardiol; 2019 Mar; 279():122-125. PubMed ID: 30638982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
    Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
    Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy.
    Te Rijdt WP; van der Klooster ZJ; Hoorntje ET; Jongbloed JDH; van der Zwaag PA; Asselbergs FW; Dooijes D; de Boer RA; van Tintelen JP; van den Berg MP; Vink A; Suurmeijer AJH
    Cardiovasc Pathol; 2017; 30():23-26. PubMed ID: 28759816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing disease causality for a novel gene variant in familial dilated cardiomyopathy using a functional in-vitro assay of regulated thin filaments and human cardiac myosin.
    Pan S; Sommese RF; Sallam KI; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM; Ashley EA
    BMC Med Genet; 2015 Oct; 16():97. PubMed ID: 26498512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study.
    Jansen M; de Brouwer R; Hassanzada F; Schoemaker AE; Schmidt AF; Kooijman-Reumerman MD; Bracun V; Slieker MG; Dooijes D; Vermeer AMC; Wilde AAM; Amin AS; Lekanne Deprez RH; Herkert JC; Christiaans I; de Boer RA; Jongbloed JDH; van Tintelen JP; Asselbergs FW; Baas AF
    JACC Heart Fail; 2024 Jan; 12(1):134-147. PubMed ID: 37565978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting secondary cardiac disease variants in an exome cohort.
    Ng D; Johnston JJ; Teer JK; Singh LN; Peller LC; Wynter JS; Lewis KL; Cooper DN; Stenson PD; Mullikin JC; Biesecker LG;
    Circ Cardiovasc Genet; 2013 Aug; 6(4):337-46. PubMed ID: 23861362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies.
    Lu C; Wu W; Liu F; Yang K; Li J; Liu Y; Wang R; Si N; Gao P; Liu Y; Zhang S; Zhang X
    J Transl Med; 2018 Aug; 16(1):241. PubMed ID: 30165862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pathogenic variants in genes related to channelopathy and cardiomyopathy in Korean sudden cardiac arrest survivors.
    Song JS; Kang JS; Kim YE; Park SJ; Park KM; Huh J; Kim JS; Cho H; Ki CS; On YK
    J Hum Genet; 2017 Jun; 62(6):615-620. PubMed ID: 28202948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy.
    Young HS; Ceholski DK; Trieber CA
    Biochem Cell Biol; 2015 Feb; 93(1):1-7. PubMed ID: 25563649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
    Truszkowska GT; Bilińska ZT; Kosińska J; Śleszycka J; Rydzanicz M; Sobieszczańska-Małek M; Franaszczyk M; Bilińska M; Stawiński P; Michalak E; Małek ŁA; Chmielewski P; Foss-Nieradko B; Machnicki MM; Stokłosa T; Ponińska J; Szumowski Ł; Grzybowski J; Piwoński J; Drygas W; Zieliński T; Płoski R
    BMC Med Genet; 2015 Apr; 16():21. PubMed ID: 25928149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
    Flesch M; Schwinger RH; Schnabel P; Schiffer F; van Gelder I; Bavendiek U; Südkamp M; Kuhn-Regnier F; Böhm M
    J Mol Med (Berl); 1996 Jun; 74(6):321-32. PubMed ID: 8862513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy.
    Meyer M; Schillinger W; Pieske B; Holubarsch C; Heilmann C; Posival H; Kuwajima G; Mikoshiba K; Just H; Hasenfuss G
    Circulation; 1995 Aug; 92(4):778-84. PubMed ID: 7641356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilated cardiomyopathy myosin mutants have reduced force-generating capacity.
    Ujfalusi Z; Vera CD; Mijailovich SM; Svicevic M; Yu EC; Kawana M; Ruppel KM; Spudich JA; Geeves MA; Leinwand LA
    J Biol Chem; 2018 Jun; 293(23):9017-9029. PubMed ID: 29666183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.